humanized chimeric IgG1 mAb (UCB pharma)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namehumanized chimeric IgG1 mAb (UCB pharma)
Drug Alias Nameanti-TcdA/anti-TcdB humanized mAb (UCB pharma)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionToxin A inhibitorsToxin B inhibitors
TargetsToxin BToxin A
Therapy Area/IndicationsClostridium Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUcb Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUcb Sa
Active IndicationsN/A
Inactive IndicationsClostridium Infections

Other Information

ATC CodeN/A
Related LinksN/A